As a women’s health & wellness company that puts science first, we encourage you to speak with a local provider to learn more about how the Viveve Solutions can help you!

Or You Can Refer Your Current Healthcare Provider Here

The Viveve System is indicated for the treatment of vaginal laxity, sexual function or urinary incontinence in more than 50 countries, and use in general surgery for electrocoagulation and hemostasis in the United States.


 Viveve Provider

  InControl Product Provider

    Home »
  1. All Viveve Service Providers
  2. »
  3. Viveve International Distributors
Search in radius 100 miles
Çukurambar Mahallesi. Muhsin Yazıcıoğlu Street. #8/1, Sarikonak
Turkey 6530



The Viveve Treatment is a nonsurgical treatment that rebuilds the tissue of the vaginal canal. The treatment prompts the production of collagen and provides a structural foundation for the urethra. This allows the vagina to regain its prior structure and function, and in turn, laxity is decreased, sensation is restored, and urinary leakage is alleviated

  • One, 30-45 minute session
  • Safe and comfortable
  • Clinically proven
  • Discreet

Finding the nearest

Providers is simple

Search by Location: You can 'allow' the site to access your location to see the closest providers to you or you can enter a country, zip code, state, or city in the 'Address' search box.

Search by Keyword: You can enter a practices name, or a providers name, to quickly find a specific provider. Submit a request if you would like your current healthcare professional to become a Viveve provider

Search the Map: Simply hover over the map with your mouse or fingers and zoom in on your preferred area. Click on the icon to 'Read More' and view the individual listing page.

Content provided on this site may not be applicable for every region. Please abide by your regional indication as follows: The Viveve System® is indicated for treatment of the vaginal introitus, after vaginal childbirth, to improve sexual function in: Australia, Brazil, Canada, Chile, Colombia, Costa Rica, Dominican Republic, Hong Kong, Japan, Malaysia, Mexico, Panama, Philippines, Singapore, United Arab Emirates, Uruguay, and Venezuela. The Viveve System is indicated for treatment of vaginal laxity in: Bahrain, EU, Iceland, Iran, Korea, Kuwait, Lebanon, Liechtenstein, Norway, Qatar, South Africa, Switzerland, Turkey, and Ukraine. The Viveve System is indicated for use in general surgery for electrocoagulation and hemostasis in: Korea, Peru, Taiwan, Thailand, and the United States.
Manage Your Listing
Viveve, Inc. 2018 All Rights Reserved